Broadcom stock fall as investors weigh guidance. Here’s what Wall Street analysts are saying.

Broadcom shares fell over 2% premarket even after fiscal Q3 revenue topped analysts’ expectations. Guidance for the November-ending quarter was viewed as potentially below market expectations, with fiscal Q4 revenue of $34.8B only marginally above the $34.7B estimate. Overall, the stock reaction suggests investors are discounting the results due to cautious near-term outlook.

Analysis

This is less a fundamental break than a positioning reset: when a name like AVGO trades on “quality growth” and the guide merely clears consensus, the first move is usually multiple compression, not an earnings-revision collapse. The risk is that investors extrapolated AI infrastructure strength too far ahead of the actual revenue conversion rate, so the stock can underperform even if underlying demand is intact.

Second-order pressure should show up in the higher-beta semi infrastructure basket. Names most exposed are the ones priced for acceleration without AVGO’s diversification and cash-flow durability; that includes networking/ASIC-adjacent peers and the SOXX/SMH complex if the market reads this as a broader “good but not great” capex signal. If investors start questioning the durability of hyperscaler spending cadence, the de-rating can last several weeks even absent any negative fundamental update.

Contrarian take: the market may be overreacting to the shape of guidance rather than the trajectory of the business. AVGO still has one of the cleanest FCF conversion profiles in tech, so unless the next catalyst shows order pushouts or margin giveback, this should be a tradable dip rather than the start of a structural rerate lower. The thesis is falsified if the next quarter’s guide or AI commentary comes in meaningfully above street and the stock reclaims the pre-earnings range quickly.

Key Decisions for Investors

• Do not chase the first post-gap move; wait 1-3 sessions for revisions to settle before adding to AVGO. If the stock reclaims the pre-earnings level on volume, buy the dip for a 1-2 month mean-reversion trade.
• Pair trade: long AVGO / short a higher-beta semi infrastructure proxy such as MRVL or the SOXX ETF for 4-8 weeks. The relative-value thesis is that AVGO’s diversification should hold up better if the market is re-rating AI duration risk.
• If already long AVGO, trim 25-30% into any intraday rebound and re-enter only if management commentary or sell-side checks confirm no change in hyperscaler capex trajectory over the next month.
• Watch for a reversal trigger: any upward revision to fiscal Q4 revenue or commentary indicating AI-related backlog conversion is accelerating. That would invalidate the “in-line equals disappointment” read-through and likely force a squeeze.
• Avoid an outright short unless there is evidence of guide leakage across the broader supplier chain; otherwise the better expression is relative-value, not directional bearishness.